An early clinical trial at U-M finds that a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment.
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Who’s Minding the Children? Female Physicians Report Skipping Scientific Conferences Because of Child Care
A survey of early career oncologists suggests onsite child care could open scientific meetings to more women attendees.
Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.
When the surgical wound doesn’t heal right, it can send some patients back to the operating room.
A U-M study is the first to define how a little-known type of cell death impacts tumor cells and immune cells.
Clinical trial shows promise of immune treatment against HPV infections that lead to cancer